Rajnish Mehrotra

Summary

Publications

  1. pmc American Society of Nephrology Quiz and Questionnaire 2013: RRT
    Rajnish Mehrotra
    Division of Nephrology, Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, Washington
    Clin J Am Soc Nephrol 9:1497-503. 2014
  2. pmc American Society of Nephrology quiz and questionnaire 2012: renal replacement therapy
    Rajnish Mehrotra
    Kidney Research Institute and Harborview Medical Center, Division of Nephrology, University of Washington, Seattle, Washington 98104, USA
    Clin J Am Soc Nephrol 8:1632-6. 2013
  3. doi request reprint Nutritional issues in peritoneal dialysis patients: how do they differ from that of patients undergoing hemodialysis?
    Rajnish Mehrotra
    Harborview Medical Center and Kidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA
    J Ren Nutr 23:237-40. 2013
  4. doi request reprint Dialysis in 2012: Could longer and more frequent haemodialysis improve outcomes?
    Rajnish Mehrotra
    Harborview Medical Center and Kidney Research Institute, Division of Nephrology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Nat Rev Nephrol 9:74-5. 2013
  5. doi request reprint Peritoneal dialysis-associated peritonitis with simultaneous exit-site infection
    Rajnish Mehrotra
    Department of Medicine, Harborview Medical Center, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Clin J Am Soc Nephrol 8:126-9; discussion 129-30. 2013
  6. pmc Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria
    Yi Wen Chiu
    Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California, USA
    Clin J Am Soc Nephrol 5:2093-100. 2010
  7. pmc No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease
    Rajnish Mehrotra
    Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, Washington, USA
    Kidney Int 84:989-97. 2013
  8. pmc Chronic kidney disease, hypovitaminosis D, and mortality in the United States
    Rajnish Mehrotra
    Division of Nephrology and Hypertension, Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California 90502, USA
    Kidney Int 76:977-83. 2009
  9. doi request reprint Coronary artery calcification and mortality in diabetic patients with proteinuria
    Yi Wen Chiu
    Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California, USA
    Kidney Int 77:1107-14. 2010
  10. pmc Hypovitaminosis D in chronic kidney disease
    Rajnish Mehrotra
    Department of Medicine, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, USA
    Clin J Am Soc Nephrol 3:1144-51. 2008

Detail Information

Publications24

  1. pmc American Society of Nephrology Quiz and Questionnaire 2013: RRT
    Rajnish Mehrotra
    Division of Nephrology, Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, Washington
    Clin J Am Soc Nephrol 9:1497-503. 2014
    ..This article recapitulates the session and reproduces its educational value for CJASN readers. Enjoy the clinical cases and expert discussions. ..
  2. pmc American Society of Nephrology quiz and questionnaire 2012: renal replacement therapy
    Rajnish Mehrotra
    Kidney Research Institute and Harborview Medical Center, Division of Nephrology, University of Washington, Seattle, Washington 98104, USA
    Clin J Am Soc Nephrol 8:1632-6. 2013
    ..This article tries to recapitulate the session and reproduce its educational value for a larger audience-the readers of the CJASN. ..
  3. doi request reprint Nutritional issues in peritoneal dialysis patients: how do they differ from that of patients undergoing hemodialysis?
    Rajnish Mehrotra
    Harborview Medical Center and Kidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA
    J Ren Nutr 23:237-40. 2013
    ..In conclusion, it is important to consider these unique nutritional considerations when providing care to patients undergoing PD...
  4. doi request reprint Dialysis in 2012: Could longer and more frequent haemodialysis improve outcomes?
    Rajnish Mehrotra
    Harborview Medical Center and Kidney Research Institute, Division of Nephrology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Nat Rev Nephrol 9:74-5. 2013
    ....
  5. doi request reprint Peritoneal dialysis-associated peritonitis with simultaneous exit-site infection
    Rajnish Mehrotra
    Department of Medicine, Harborview Medical Center, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Clin J Am Soc Nephrol 8:126-9; discussion 129-30. 2013
    ..aureus or Pseudomonas peritonitis who also have exit-site infection with the same organism, after the intraperitoneal infection has responded to antibiotic therapy...
  6. pmc Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria
    Yi Wen Chiu
    Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California, USA
    Clin J Am Soc Nephrol 5:2093-100. 2010
    ....
  7. pmc No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease
    Rajnish Mehrotra
    Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, Washington, USA
    Kidney Int 84:989-97. 2013
    ..Thus, in the largest cohort of individuals with early-stage CKD to date, we could not validate an independent association of serum phosphorus with risk for death or progression to ESRD...
  8. pmc Chronic kidney disease, hypovitaminosis D, and mortality in the United States
    Rajnish Mehrotra
    Division of Nephrology and Hypertension, Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California 90502, USA
    Kidney Int 76:977-83. 2009
    ..Randomized, controlled trials are needed to conclusively determine whether vitamin D supplementation reduces mortality...
  9. doi request reprint Coronary artery calcification and mortality in diabetic patients with proteinuria
    Yi Wen Chiu
    Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California, USA
    Kidney Int 77:1107-14. 2010
    ..Additional studies need to determine whether altering the natural history of coronary artery calcification in early chronic kidney disease prolongs survival...
  10. pmc Hypovitaminosis D in chronic kidney disease
    Rajnish Mehrotra
    Department of Medicine, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, USA
    Clin J Am Soc Nephrol 3:1144-51. 2008
    ....
  11. pmc Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review
    Scott D Bieber
    University of Washington, Seattle, WA Electronic address
    Am J Kidney Dis 63:1027-37. 2014
    ..Given these considerations, it appears that patient choice should drive the decision about PD modality. ..
  12. doi request reprint Initiation of dialysis should be timely: neither early nor late
    Rajnish Mehrotra
    Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
    Semin Dial 26:644-9. 2013
    ..volume overload, refractory hyperkalemia). Finally, there is a compelling need to reexamine the symptoms that could be attributed to uremia and clearly improve upon initiation of dialysis to better guide clinical decision-making. ..
  13. doi request reprint Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence?
    Rajnish Mehrotra
    Kidney Research Institute, University of Washington, Seattle, Washington, USA
    Curr Opin Nephrol Hypertens 22:663-8. 2013
    ..In this review, we examine the evidence linking this obligatory absorption with adverse systemic effects...
  14. doi request reprint Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients
    Connie M Rhee
    Harold Simmons Center for Chronic Disease Research and Epidemiology C M R, K K Z, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California 92868 Los Angeles Biomedical Research Institute C M R, K K Z, Harbor UCLA Medical Center Torrance, California 90502 Department of Statistics S K, D L G, T O, J W, University of California Irvine School of Medicine, Irvine, California 92697 Division of Nephrology R M, S K, Harborview Medical Center, University of Washington, Seattle, Washington 98104 Division of General Internal Medicine D V N, University of California Irvine Medical Center, Orange, California 92868 DaVita Clinical Research S M B, Minneapolis, Minnesota 55404 Nephrology Section C P K, Memphis Veterans Affairs Medical Center, Memphis, Tennessee 38104 Division of Nephrology C P K, University of Tennessee Health Science Center, Memphis, Tennessee 38163 and Division of Endocrinology G A B, University of California Los Angeles, Los Angeles, California 90095
    J Clin Endocrinol Metab 100:1386-95. 2015
    ..Despite their heightened cardiovascular mortality, the impact of hypothyroidism on the survival of hemodialysis patients remains uncertain...
  15. pmc Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis
    Connie M Rhee
    Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine, Orange, California Division of Nephrology, Brigham and Women s Hospital, Boston, Massachusetts, USA Division of Nephrology and Hypertension, University of California Irvine, Irvine, California, USA Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada Division of Nephrology, Memphis Veterans Affairs Medical Center, and Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee, USA Harborview Medical Center, University of Washington, Seattle, Washington, USA Department of Epidemiology, UCLA School of Public Health, Los Angeles, California, USA Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine, Orange, California Division of Nephrology, Brigham and Women s Hospital, Boston, Massachusetts, USA Division of Nephrology and Hypertension, University of California Irvine, Irvine, California, USA Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada Division of Nephrology, Case Western Reserve University
    Perit Dial Int 34:732-48. 2014
    ..In hemodialysis (HD) patients, serum alkaline phosphatase (ALP) and parathyroid hormone (PTH) derangements are associated with mortality, but outcome-predictability using ALP and PTH in peritoneal dialysis (PD) patients remains uncertain...
  16. pmc Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials
    Ian H De Boer
    Division of Nephrology, Department of Medicine, Seattle, WA Kidney Research Institute, Department of Medicine, Seattle, WA Department of Epidemiology, University of Washington, Seattle, WA Electronic address
    Am J Kidney Dis 64:187-97. 2014
    ..We tested associations of estimated GFR (eGFR) with the circulating concentration of 24,25-dihydroxyvitamin D3 (24,25[OH]2D3), the most abundant product of 25(OH)D3 catabolism, across populations with a wide range of GFRs...
  17. ncbi request reprint Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion
    Csaba P Kovesdy
    Division of Nephrology, Salem Veterans Affairs Medical Center, Salem, Virginia 24153, USA
    Clin J Am Soc Nephrol 3:168-73. 2008
    ..Also assessed is what the key unanswered questions are in this field, and practical solutions to the discussed issues are provided...
  18. pmc A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients
    Matthew B Rivara
    Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington Kidney Research Institute, Seattle, Washington Electronic address
    J Ren Nutr 25:40-9. 2015
    ..The secondary aim was to assess the effect of pomegranate supplementation on oxidative stress, systemic inflammation, monocyte function, and blood pressure...
  19. pmc Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment
    Ian H De Boer
    Division of Nephrology and Kidney Research Institute, Department of Medicine, University of Washington, Seattle, Washington, USA
    Kidney Int 86:243-5. 2014
    ..These findings move forward the study of insulin resistance in CKD and generate new questions for future work. ..
  20. pmc Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach
    Amy Barton Pai
    Department of Pharmacy Practice, ANephRx Albany Nephrology Pharmacy Group, Albany College of Pharmacy and Health Sciences, Albany, New York, Reach Medication Therapy Management, Dialysis Clinic, Inc, Albany, New York, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, US Renal Data System and Chronic Disease Research Group, Minneapolis, Minnesota, Policy and Government Affairs, American Society of Nephrology, Washington, DC, Division of Nephrology, Boston Children s Hospital, Boston, Massachusetts, Division of Nephrology, Harborview Medical Center and Kidney Research Institute, University of Washington, Seattle, Washington
    Clin J Am Soc Nephrol 8:1988-99. 2013
    ..Herein, this work provides a review of available evidence and recommendations for optimal delivery of medication management services to ESRD patients in a dialysis facility-centered model. ..
  21. pmc Dialysis therapies: a National Dialogue
    Rajnish Mehrotra
    Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, Ohio State University, Columbus, Ohio, University Health Network, Toronto, Ontario, Canada, University of California, San Francisco, California, Oregon Health and Science University, Portland, Oregon, Emory University, Atlanta, Georgia, National Institute of Diabetes, Digestive, and Kidney Disease, National Institutes of Health, Bethesda, Maryland
    Clin J Am Soc Nephrol 9:812-4. 2014
    ..Together, these research objectives provide a path forward for improving patient-centered outcomes in ESRD. ..
  22. doi request reprint Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis
    David G Warnock
    Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala, USA
    Contrib Nephrol 178:157-63. 2012
    ..In addition to assessing the safety of bardoxolone methyl in this population, the study will evaluate the effect of bardoxolone methyl on residual renal function over 6 months as compared to placebo...
  23. ncbi request reprint Serum and dialysate potassium concentrations and survival in hemodialysis patients
    Csaba P Kovesdy
    Division of Nephrology, Salem Veterans Affairs Medical Center, Salem, Virginia, USA
    Clin J Am Soc Nephrol 2:999-1007. 2007
    ..Controlling serum potassium is an important goal in maintenance hemodialysis patients. We examined the achievement of potassium balance through hemodialysis treatments and the associated fluctuations in serum potassium...
  24. pmc Racial differences in mortality among those with CKD
    Rajnish Mehrotra
    Department of Medicine, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    J Am Soc Nephrol 19:1403-10. 2008
    ..This higher risk for death in early stages of CKD may explain the apparent survival advantage observed among black individuals who live long enough to reach stage 5 CKD...